Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -13,110.24%-21.6M | ---- | 225.76%166K | ---- | 96.65%-132K | ---- | 51.46%-3.95M | ---- | 79.43%-8.13M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 66.19%-94K | ---- | ---278K | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | 1,877.23%7.55M | ---- | 158.14%382K | ---- | -141.09%-657K | ---- | 504.81%1.6M | ---- | -101.38%-395K |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -71.28%677K | ---- | --2.36M |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | -171.26%-657K | ---- | 133.50%922K | ---- | -256.19%-2.75M |
| -Other impairments and provisions | ---- | 1,877.23%7.55M | ---- | --382K | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -58.82%42K |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -58.82%42K |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---235K | ---- | ---- | ---- | -783.67%-1.34M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---103K | ---- | ---- | ---- | ---1.34M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---132K | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 518.10%4.17M | ---- | 0.90%674K | ---- | -64.28%668K | ---- | -50.48%1.87M | ---- | 10.83%3.78M |
| Financial expense | ---- | 619.35%446K | ---- | -40.95%62K | ---- | -52.49%105K | ---- | -34.03%221K | ---- | -2.90%335K |
| Special items | ---- | --880K | ---- | ---- | ---- | 3.93%-293K | ---- | 64.16%-305K | ---- | -1,318.33%-851K |
| Operating profit before the change of operating capital | ---- | -959.44%-8.65M | ---- | 284.93%1.01M | ---- | 2.86%-544K | ---- | 91.46%-560K | ---- | 5.62%-6.56M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 126.22%328K | ---- | -1,169.23%-1.25M | ---- | -35.36%117K | ---- | 245.97%181K | ---- | 63.31%-124K |
| Accounts receivable (increase)decrease | ---- | 135.39%7.97M | ---- | -305.88%-22.52M | ---- | 176.03%10.94M | ---- | -1,598.35%-14.39M | ---- | -914.42%-847K |
| Accounts payable increase (decrease) | ---- | -139.76%-7.58M | ---- | 295.49%19.05M | ---- | -191.84%-9.75M | ---- | 346.82%10.61M | ---- | 465.48%2.38M |
| prepayments (increase)decrease | ---- | 101.57%82K | ---- | -4,171.31%-5.21M | ---- | 97.76%-122K | ---- | -111.72%-5.45M | ---- | 3,647.34%46.47M |
| Special items for working capital changes | ---- | -144.75%-2.68M | ---- | 325.48%6M | ---- | -59.66%1.41M | ---- | 2,213.25%3.49M | ---- | 10.22%151K |
| Cash from business operations | ---- | -259.71%-10.53M | ---- | -242.66%-2.93M | ---- | 133.59%2.05M | ---- | -114.73%-6.11M | ---- | 869.36%41.46M |
| Other taxs | ---- | -295.78%-603K | ---- | 1,093.55%308K | ---- | 27.91%-31K | ---- | ---43K | ---- | ---- |
| Interest paid - operating | ---- | -512.90%-380K | ---- | ---62K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of business | 107.64%331K | ---- | -1,099.72%-4.33M | ---- | -131.83%-361K | ---- | 114.54%1.13M | ---- | -125.23%-7.8M | ---- |
| Net cash from operations | 107.64%331K | -329.40%-11.51M | -1,099.72%-4.33M | -232.67%-2.68M | -131.83%-361K | 132.85%2.02M | 114.54%1.13M | -114.83%-6.15M | -125.23%-7.8M | 869.36%41.46M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -66.19%94K | ---- | --278K | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | --1.34M | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | ---- | -524.95%-6.81M | ---- | -86.64%-1.09M | ---- | 18.66%-584K | ---- | 58.18%-718K | ---- | -7.18%-1.72M |
| Sale of subsidiaries | ---- | ---39K | ---- | ---- | ---- | ---2K | ---- | ---- | ---- | ---565K |
| Other items in the investment business | -78.86%-6.52M | ---- | -501.82%-3.65M | ---- | ---606K | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -78.86%-6.52M | -732.14%-6.76M | -501.82%-3.65M | -207.12%-812K | ---606K | 205.57%758K | ---- | 68.54%-718K | ---- | -567.25%-2.28M |
| Net cash before financing | 22.39%-6.19M | -423.05%-18.27M | -725.03%-7.98M | -225.70%-3.49M | -185.27%-967K | 140.45%2.78M | 114.54%1.13M | -117.53%-6.87M | -125.62%-7.8M | 783.63%39.18M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 4,161.45%3.54M | ---- | 108.88%83K | ---- | -201.52%-935K | ---- | 107.95%921K | ---- | ---11.58M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10.08M | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | --529K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | 1,948.40%6.95M | ---- | 7.62%-376K | ---- | 66.99%-407K | ---- | ---1.23M | ---- | ---- | ---- |
| Net cash from financing operations | 1,948.40%6.95M | 950.37%1.15M | 7.62%-376K | 93.65%-135K | 66.99%-407K | -124.27%-2.13M | ---1.23M | 163.53%8.76M | ---- | -758.09%-13.79M |
| Effect of rate | ---- | 82.81%-33K | ---- | -262.26%-192K | ---- | ---53K | ---- | ---- | ---- | ---- |
| Net Cash | 109.07%758K | -371.93%-17.12M | -508.01%-8.35M | -656.29%-3.63M | -1,287.88%-1.37M | -65.54%652K | 98.73%-99K | -92.55%1.89M | -142.28%-7.8M | 798.35%25.39M |
| Begining period cash | -68.03%8.06M | -13.16%25.21M | -13.16%25.21M | 2.11%29.03M | 2.11%29.03M | 7.13%28.43M | 7.13%28.43M | 2,213.78%26.54M | 5,155.25%26.54M | -76.02%1.15M |
| Cash at the end | -47.68%8.82M | -68.03%8.06M | -39.05%16.86M | -13.16%25.21M | -2.39%27.66M | 2.11%29.03M | 51.18%28.33M | 7.13%28.43M | -1.12%18.74M | 2,213.78%26.54M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Jiuan (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.